SurfWax News Index  |  Track News  |  Save/Exchange Information |  WikiWax |  About Us News and Articles on Quigley Corporation (QGLY)   CBS Marketwatch Quote Chart Yahoo! Finance: Profile Key Statistics SEC Filings MSN Money Earnings Estimates Financial Results Insider Trading   Cold-EEZE(R) Lozenges not Affected by FDA Advisory for Zicam(R) Intra-Nasal Products  Jun 17, 2009 While these products are manufactured with a zinc ingredient, The Quigley Corporation (Nasdaq: ), , maker of the popular line of Cold-EEZE(R) zinc gluconate lozenges, assures consumers that their oral zinc lozenge products are not involved in this new FDA advisory, and that the Cold-EEZE(R) brand continues to be supported as safe and effective in clinical research ... "The FDA has made a determination that the Zicam intra-nasal products have a growing body of evidence suggesting that they may... (PR Newswire) The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain  Jun 2, 2009 June 1 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: ), , today announced that IVS Associates, Inc., the inspector of election for Quigley's 2009 annual meeting of shareholders, issued its final report, showing that Ted Karkus' seven director nominees received a larger number of votes than Quigley's incumbent directors ... Karkus had previously stated in sworn testimony that at no time did he have any financial arrangement with any employee of The Quigley Corporation ... About The... (PR Newswire) Ted Karkus Admits to Financial Relationship With Dr. Richard A. Rosenbloom; Demonstrates Pattern of Improper Influence, Unethical Behavior, Falsification and Distortion; Company Questions What Else Karkus May Be Hiding From Shareholders  May 20, 2009 May 19 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: ), , today announced that it has uncovered additional facts with respect to the relationship between Ted Karkus and Dr. Richard Rosenbloom ... Karkus is, and has been, a shareholder of The Quigley Corporation and Dr. Rosenbloom is, and has been, in possession of material non-public information as to the Company's drug candidate development programs during the term of the loan ... In sworn testimony, Karkus stated that at no time... (PR Newswire) Back to Company News News [ Terms Of Use | Privacy | About ] ©1998-2006 SurfWax, Inc. All rights reserved. Patents pending. Copyright SurfWax, Inc. 2006